Definitive Contract 75N91020C00051

Award Date 9/16/20
Potential Completion Date 9/15/21
Potential Value $392K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
18
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Reveal Biosciences Inc., a small disadvantaged business based in San Diego, CA. The $386,940 firm-fixed-price contract was issued under a Small Business Innovation Research (SBIR) solicitation focused on developing "Tools and Technologies for Visualizing Multi-Scale Data" to support cancer research and prevention efforts. Reveal Biosciences specializes...
This is a $370,804.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the U.S. Department of Health and Human Services (HHS), to Reveal Biosciences Inc. The contract is for the development of an image-based platform to comprehensively de-identify whole slide imaging (WSI) data for cancer research. This was a total small business set-aside contract. Reveal Biosciences is a computational...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Phenomapper, LLC, a minority-owned, self-certified small disadvantaged business located in San Jose, California. The $398,952.00 firm-fixed-price contract was awarded on September 16, 2020, with a completion date of September 15, 2021. The contract is for the development of artificial intelligence-aided imaging technology...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Babel Analytics LLC, a self-certified small disadvantaged business, woman-owned small business, and Asian-Pacific American-owned limited liability company. The contract, valued at $447,633.00, is for the development of Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. This SBIR Phase I...
This is a $455,000 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Carina Medical LLC, a minority-owned small business. The contract supports research and development of artificial intelligence (AI)-aided imaging technologies for cancer prevention, diagnosis, and monitoring. This work aligns with the NCI's mission and the SBIR program's goals of stimulating...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $2 million firm fixed price definitive contract to Carina Medical LLC as a total small business set aside. The contract is for Fiscal Year 2023 Small Business Innovation Research Topic 402 Phase II efforts to enhance the performance of artificial intelligence for lymph node detection, segmentation and measurements in multi-modality medical imaging, and to develop additional...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Reveal Biosciences Inc., a self-certified small disadvantaged business, for SBIR Phase I efforts on the topic of "Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring." The potential value of the contract is $392,343.00. Reveal Biosciences is a computational pathology company that develops AI-enabled imaging platforms for cancer research and diagnosis. This contract is a Total Small Business set-aside and is part of the NIH's Small Business Innovation Research (SBIR) program, which supports small businesses in creating innovative technologies to address high-priority research and development needs.

Generated 3/22/24, 8:41 PM